Zhang J - Search Results

1

Evolutionary Dynamics and Intermittent Therapy for Metastatic Cancers.

Chahoud J, Anderson ARA, Zhang J, Brown J, Gatenby RA. Chahoud J, et al. Among authors: zhang j. J Clin Oncol. 2023 Oct 1;41(28):4469-4471. doi: 10.1200/JCO.23.00647. Epub 2023 Jul 7. J Clin Oncol. 2023. PMID: 37418680

2

Spatial vs. non-spatial eco-evolutionary dynamics in a tumor growth model.

You L, Brown JS, Thuijsman F, Cunningham JJ, Gatenby RA, Zhang J, Staňková K. You L, et al. Among authors: zhang j. J Theor Biol. 2017 Dec 21;435:78-97. doi: 10.1016/j.jtbi.2017.08.022. Epub 2017 Sep 21. J Theor Biol. 2017. PMID: 28870617

3

Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer.

Zhang J, Cunningham JJ, Brown JS, Gatenby RA. Zhang J, et al. Nat Commun. 2017 Nov 28;8(1):1816. doi: 10.1038/s41467-017-01968-5. Nat Commun. 2017. PMID: 29180633 Free PMC article. Clinical Trial.

4

Multidrug Cancer Therapy in Metastatic Castrate-Resistant Prostate Cancer: An Evolution-Based Strategy.

West JB, Dinh MN, Brown JS, Zhang J, Anderson AR, Gatenby RA. West JB, et al. Among authors: zhang j. Clin Cancer Res. 2019 Jul 15;25(14):4413-4421. doi: 10.1158/1078-0432.CCR-19-0006. Epub 2019 Apr 16. Clin Cancer Res. 2019. PMID: 30992299 Free PMC article.

5

First Strike-Second Strike Strategies in Metastatic Cancer: Lessons from the Evolutionary Dynamics of Extinction.

Gatenby RA, Zhang J, Brown JS. Gatenby RA, et al. Among authors: zhang j. Cancer Res. 2019 Jul 1;79(13):3174-3177. doi: 10.1158/0008-5472.CAN-19-0807. Epub 2019 Jun 20. Cancer Res. 2019. PMID: 31221821 Free PMC article.

6

Towards Multidrug Adaptive Therapy.

West J, You L, Zhang J, Gatenby RA, Brown JS, Newton PK, Anderson ARA. West J, et al. Among authors: zhang j. Cancer Res. 2020 Apr 1;80(7):1578-1589. doi: 10.1158/0008-5472.CAN-19-2669. Epub 2020 Jan 16. Cancer Res. 2020. PMID: 31948939 Free PMC article.

7

Prostate-specific antigen dynamics predict individual responses to intermittent androgen deprivation.

Brady-Nicholls R, Nagy JD, Gerke TA, Zhang T, Wang AZ, Zhang J, Gatenby RA, Enderling H. Brady-Nicholls R, et al. Among authors: zhang t, zhang j. Nat Commun. 2020 Apr 9;11(1):1750. doi: 10.1038/s41467-020-15424-4. Nat Commun. 2020. PMID: 32273504 Free PMC article.

8

Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration.

Abida W, Patnaik A, Campbell D, Shapiro J, Bryce AH, McDermott R, Sautois B, Vogelzang NJ, Bambury RM, Voog E, Zhang J, Piulats JM, Ryan CJ, Merseburger AS, Daugaard G, Heidenreich A, Fizazi K, Higano CS, Krieger LE, Sternberg CN, Watkins SP, Despain D, Simmons AD, Loehr A, Dowson M, Golsorkhi T, Chowdhury S; TRITON2 investigators. Abida W, et al. Among authors: zhang j. J Clin Oncol. 2020 Nov 10;38(32):3763-3772. doi: 10.1200/JCO.20.01035. Epub 2020 Aug 14. J Clin Oncol. 2020. PMID: 32795228 Free PMC article.

9

Response to Mistry.

Zhang J, Cunningham JJ, Brown JS, Gatenby RA. Zhang J, et al. Nat Commun. 2021 Jan 12;12(1):329. doi: 10.1038/s41467-020-20175-3. Nat Commun. 2021. PMID: 33436553 Free PMC article. No abstract available.

10

Budget Impact of Adaptive Abiraterone Therapy for Castration-Resistant Prostate Cancer.

Mason NT, Burkett JM, Nelson RS, Pow-Sang JM, Gatenby RA, Kubal T, Peabody JW, Letson GD, McLeod HL, Zhang J. Mason NT, et al. Among authors: zhang j. Am Health Drug Benefits. 2021 Mar;14(1):15-20. Am Health Drug Benefits. 2021. PMID: 33841621 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

165,461 results

Search Page